Stock 1BT ENLIVEX THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Enlivex Therapeutics Ltd. Deutsche Boerse AG

Equities

1BT

IL0011319527

Real-time Estimate Tradegate
Other stock markets
 11:42:21 2024-06-26 EDT 		5-day change 1st Jan Change
1.315 EUR +2.73% Intraday chart for Enlivex Therapeutics Ltd. +5.98% -46.09%
06-24 Enlivex Therapeutics Says First Patient Dosed in Phase 1/2 Thumb Osteoarthritis Trial MT
06-24 Enlivex Therapeutics Ltd. Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb Osteoarthritis CI

Evolution of the average Target Price on Enlivex Therapeutics Ltd.

Price target over the last 5 years

History of analyst recommendation changes

630bd9ac9b9786.7bpoZeXoqTW2iWqEkALRgWX5LkPA3aYgAlxjz20Se3o.2ItFIYfd6E_k2F3O3E6W8lGNcQrt78B6Vh0ZjAx_VkzUyiIMktz4XcDAGQ~50f86bc34e0d27ffa57eae9b455c431f

Analyst Recommendations on Enlivex Therapeutics Ltd.

HC Wainwright Adjusts Price Target on Enlivex Therapeutics to $6 From $7, Maintains Buy Rating MT
HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating MT
HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating MT
HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.36 USD
Average target price
6 USD
Spread / Average Target
+341.18%
High Price Target
6 USD
Spread / Highest target
+341.18%
Low Price Target
6 USD
Spread / Lowest Target
+341.18%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Enlivex Therapeutics Ltd.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. 1BT Stock
  5. Consensus Enlivex Therapeutics Ltd.